Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India

International Journal of Tuberculosis and Lung Disease

Volumn 9, Issue 5, 2005, Pages 556-561

  Thomas, A ^a   Gopi, P G ^a   Santha, T ^a   Chandrasekaran, V ^a   Subramani, R ^a   Selvakumar, N ^a   Eusuff, S I ^a   Sadacharam, K ^a   Narayanan, P R ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

DOTS; India; Relapse; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADULT; ARTICLE; COHORT ANALYSIS; COUNSELING; FEMALE; FLUORESCENCE MICROSCOPY; FOLLOW UP; HUMAN; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; RELAPSE; RISK FACTOR; SHORT COURSE THERAPY; SMOKING; SMOKING CESSATION; SPUTUM EXAMINATION; TREATMENT OUTCOME;

ADULT; DIRECTLY OBSERVED THERAPY; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; RECURRENCE; RISK FACTORS; SMOKING; SMOKING CESSATION; TUBERCULOSIS, PULMONARY;

EID: 18444406295     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Revised National Tuberculosis Control Programme. Technical guidelines for TB control. Central TB Division, Directorate General of Health Services. New Delhi, India: Nirman Bhavan, 1997.
2. Studies on the treatment of tuberculosis. British Medical Research Council Tuberculosis Unit 1946-1986. Int J Tuberc Lung Dis 1999; 3 (Suppl 2): 10.
3. Central TB Division. TB India 2004: RNTCP Status Report. New Delhi, India: Directorate General of Health Services, Government of India, 2004. www.tbcindia.org Accessed March 2005.
4. Host E, Mitchison D A, Radhakrishna S. Examination of smear for tubercle bacilli by fluorescence microscopy. Indian J Med Res 1959; 47: 495-499.
5. Allen B, Baker F J. Mycobacteria: isolation, identification and sensitivity testing. London, UK: Butterworth, 1968.
6. Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
7. Santha T, Garg R, Frieden T R, et al. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS Programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis 2002; 6: 780-788.
8. Central TB Division. TB India 2003: RNTCP Status Report. Directorate General of Health Services. New Delhi, India: Ministry of Health and Family Welfare, 2003.
9. Balasubramanian R. Fully intermittent 6-month regimens for pulmonary tuberculosis in south India. Indian J Tuberc 1991; 38: 51-53.
10. Tuberculosis Research Centre. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis-a unique approach. Trop Med Int Health 2004; 9: 551-558.
11. Kolappan C, Gopi P G. Tobacco smoking and pulmonary tuberculosis. Thorax 2002; 57: 964-966.
12. Leung C C, Yew W W, Chan C K, et al. Smoking and tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2003; 7: 980-986.
13. Boelaert J R, Gomes M S, Gordeuk V R. Smoking, iron and TB. Lancet 2003; 362: 1243-1244.
14. Mateos F, Brock J H, Perez-Arellano J L. Iron metabolism in the lower respiratory tract. Thorax 1998; 53: 594-600.
15. Weiss G, Werner-Felmayer G, Werner E R, Grunewald K, Wachter H, Hentze M W. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J Exp Med 1994; 180: 969-979.
16. Dholakia Y, Danani U, Desai C. Relapse following directly observed therapy short course (DOTS)-a follow up study. Indian J Tuberc 2000; 47: 233-236.
17. Second East African/British Medical Research Council Study. Controlled clinical trial of four 6 month regimens of chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis 1976; 114: 471-475.
18. Tuberculosis Research Centre. Study of chemotherapy regimens of 5 and 7 months duration and the role of corticosteroids in the treatment of sputum positive patients with pulmonary tuberculosis in south India. Tubercle 1983; 64: 73-91.
19. Tuberculosis Research Centre. A controlled clinical trial of oral short course regimens in the treatment of sputum positive pulmonary tuberculosis. Int J Tuberc Lung Dis 1997; 16: 509-517.
20. Mitchison D A, Nunn A J. Influence of initial drug resistance on the response to treatment of pulmonary tuberculosis. Am Rev Respir Dis 1986; 133: 423-430.
21. Tuberculosis Research Centre. Low rate of emergence of drug resistance in sputum positive patients treated with short course chemotherapy. Int J Tuberc Lung Dis 2001; 5: 40-45.
22. Zhang H, Cai B. The impact of tobacco on lung health in China. Respirology 2003; 8: 17-21.
23. Frieden T R, Mostashari F, Kerker B D, Miller N, Hajat A, Frankel M. Rapid decline in adult tobacco use following intensive tobacco control measures, New York City 2002-2003. Am J Public Health 2005 (in press).